💊 Pharmaceuticals — Top Stocks by Market Cap
1,859 companies · updated every 5–20 min
| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 201 | $50.39 | -0.36% | +0.70% | $4.75B €4.25B | 1.13M shrs $56.74M | ||
| 202 | ¥25.07 | +2.62% | -1.52% | ¥34.38B $4.74B · €4.25B | 11.72M shrs ¥293.86M | ||
| 203 | ¥77.35 | -6.32% | +32.40% | ¥34.31B $4.74B · €4.24B | 3.9M shrs ¥302.04M | ||
| 204 | ₹2416.10 | +0.30% | +4.16% | ₹387.93B $4.66B · €4.17B | 4.78M shrs ₹11.55B | ||
| 205 | ₹2412.25 | +0.00% | +3.99% | ₹387.31B $4.65B · €4.16B | 68.03K shrs ₹164.1M | ||
| 206 | $82.38 | -0.39% | +3.06% | $4.61B €4.12B | 496.89K shrs $40.93M | ||
| 207 | ¥29.89 | -1.19% | +10.32% | ¥33.32B $4.60B · €4.12B | 11.03M shrs ¥329.81M | ||
| 208 | £0.17 | +0.41% | +0.59% | £3.58B $4.55B · €4.07B | 249.68K shrs £4.32M | ||
| 209 | ¥13.49 | +4.74% | -0.32% | ¥32.29B $4.46B · €3.99B | 52.22M shrs ¥704.49M | ||
| 210 | ¥26.46 | +5.00% | -2.71% | ¥32.08B $4.43B · €3.96B | 18.71M shrs ¥495M | ||
| 211 | ₩77700.00 | -0.13% | +0.00% | ₩6.08T $4.38B · €3.92B | 149.31K shrs ₩11.6B | ||
| 212 | ¥19.13 | -1.65% | -2.51% | ¥31.22B $4.31B · €3.86B | 13.28M shrs ¥254.04M | ||
| 213 | ¥4.73 | +0.64% | -3.03% | ¥31.18B $4.30B · €3.85B | 38.73M shrs ¥183.2M | ||
| 214 | 3SBio Inc. 1530.HK🇭🇰HKD | HK$13.54 | -1.53% | +4.97% | HK$33.53B $4.29B · €3.84B | 15.62M shrs HK$211.45M | |
| 215 | ¥40.30 | +0.80% | +1.48% | ¥31.03B $4.28B · €3.83B | 5.88M shrs ¥236.97M | ||
| 216 | ₹1871.80 | +0.36% | +0.79% | ₹355.1B $4.26B · €3.81B | 82.63K shrs ₹154.67M | ||
| 217 | ₹1868.10 | +0.23% | +2.07% | ₹354.4B $4.25B · €3.81B | 2.04K shrs ₹3.82M | ||
| 218 | ¥47.93 | +1.27% | +1.63% | ¥30.67B $4.23B · €3.79B | 4.59M shrs ¥220M | ||
| 219 | $38.90 | -0.03% | +0.82% | $4.22B €3.78B | 967.48K shrs $37.63M | ||
| 220 | $21.63 | -3.00% | +2.01% | $4.21B €3.77B | 2.19M shrs $47.34M | ||
| 221 |  REST EZ INC RTEZ🇺🇸USD | $70.00 | +0.00% | +0.00% | $4.2B €3.76B | 100 shrs $7K | |
| 222 | $35.37 | +0.34% | +0.73% | $4.17B €3.74B | 4.4M shrs $155.53M | ||
| 223 | ¥28.96 | -2.95% | +17.98% | ¥29.73B $4.10B · €3.67B | 13.09M shrs ¥378.98M | ||
| 224 | NT$159.00 | -1.55% | +6.12% | NT$131.84B $4.09B · €3.66B | 3.7M shrs NT$587.91M | ||
| 225 | ₩75100.00 | +0.54% | -3.04% | ₩5.61T $4.04B · €3.62B | 296.76K shrs ₩22.29B | ||
| 226 | $45.06 | +0.16% | +7.13% | $4.03B €3.61B | 2.09M shrs $94.2M | ||
| 227 | $32.07 | +0.31% | -1.64% | $4.03B €3.61B | 1.88M shrs $60.38M | ||
| 228 | ¥23.05 | -0.52% | -0.70% | ¥29.14B $4.02B · €3.60B | 5.27M shrs ¥121.37M | ||
| 229 | ¥32.11 | -1.17% | +29.34% | ¥28.78B $3.97B · €3.56B | 3.58M shrs ¥114.81M | ||
| 230 | $18.05 | -7.27% | +1.83% | $3.96B €3.54B | 1.33M shrs $23.95M | ||
| 231 | ¥69.69 | -2.30% | +6.99% | ¥28.43B $3.92B · €3.51B | 5.8M shrs ¥404.44M | ||
| 232 | kr 670.00 | +0.00% | +6.46% | kr 39.87B $3.87B · €3.46B | 74.59K shrs kr 49.98M | ||
| 233 | $11.86 | -9.37% | +34.99% | $3.84B €3.44B | 1.85M shrs $21.88M | ||
| 234 | $31.27 | -0.06% | +0.13% | $3.83B €3.43B | 1.45M shrs $45.4M | ||
| 235 | $8.43 | -11.87% | -10.59% | $3.82B €3.42B | 6.6M shrs $55.65M | ||
| 236 | ¥1770.50 | +0.97% | +6.38% | ¥568.83B $3.81B · €3.41B | 1.82M shrs ¥3.22B | ||
| 237 | ₩39700.00 | -2.34% | -5.86% | ₩5.28T $3.80B · €3.40B | — | ||
| 238 | $22.53 | +1.35% | +1.20% | $3.8B €3.40B | 3.37M shrs $75.93M | ||
| 239 | ₹1922.90 | +0.50% | -2.37% | ₹312.49B $3.75B · €3.36B | 496.45K shrs ₹954.62M | ||
| 240 | ₹1921.45 | +0.46% | -2.59% | ₹312.26B $3.75B · €3.35B | 32.54K shrs ₹62.52M | ||
| 241 | R 1.59 | +0.00% | +4.78% | R 68.9B $3.72B · €3.33B | 454.5K shrs R 72.33M | ||
| 242 | $82.84 | -0.43% | +6.39% | $3.68B €3.29B | 686.45K shrs $56.87M | ||
| 243 | ₹230.78 | -0.87% | -0.21% | ₹306.03B $3.67B · €3.29B | 26.36M shrs ₹6.08B | ||
| 244 | ₹230.60 | -0.95% | +6.24% | ₹305.8B $3.67B · €3.28B | 1.43M shrs ₹329.36M | ||
| 245 | $37.54 | +3.30% | +10.42% | $3.64B €3.25B | 1.54M shrs $57.95M | ||
| 246 |  Organon & Co. OGN🇺🇸USD | $13.81 | +0.22% | +0.59% | $3.63B €3.25B | 2.51M shrs $34.66M | |
| 247 | HK$4.50 | -1.21% | -5.57% | HK$28.24B $3.61B · €3.24B | 6.58M shrs HK$29.56M | ||
| 248 | $28.68 | +2.17% | +9.65% | $3.6B €3.22B | 905.04K shrs $25.96M | ||
| 249 | $20.76 | +2.17% | +11.50% | $3.58B €3.20B | 2.19M shrs $45.54M | ||
| 250 | ¥55.38 | -4.68% | +14.00% | ¥25.76B $3.56B · €3.18B | 6.18M shrs ¥342.35M | ||
| 251 | ₩388500.00 | +5.14% | +8.19% | ₩4.93T $3.55B · €3.18B | — | ||
| 252 | ¥15.24 | -1.17% | -0.58% | ¥25.46B $3.51B · €3.15B | 12.9M shrs ¥196.62M | ||
| 253 | HK$49.92 | -1.34% | +5.31% | HK$27.22B $3.48B · €3.12B | 401.34K shrs HK$20.04M | ||
| 254 | Fr 70.80 | -2.07% | +6.20% | Fr 3.1B $3.47B · €3.11B | 139.18K shrs Fr 9.85M | ||
| 255 | $74.20 | +2.98% | -7.98% | $3.47B €3.11B | 456.69K shrs $33.89M | ||
| 256 | $32.92 | -4.94% | +7.71% | $3.47B €3.11B | 843.04K shrs $27.75M | ||
| 257 | C$12.41 | +28.34% | +5.59% | C$4.64B $3.43B · €3.07B | 3.43M shrs C$42.53M | ||
| 258 | €61.55 | +0.41% | -2.71% | €3.15B $3.43B | 76.65K shrs €4.72M | ||
| 259 | ¥26.88 | +0.64% | -13.98% | ¥24.78B $3.42B · €3.06B | 5.33M shrs ¥143.25M | ||
| 260 | $26.86 | +5.91% | +7.67% | $3.42B €3.06B | 6.74M shrs $181.07M | ||
| 261 | $6.86 | -5.64% | -27.53% | $3.4B €3.05B | 177.56K shrs $1.22M | ||
| 262 | HK$10.38 | +0.68% | +6.49% | HK$26.54B $3.40B · €3.04B | 4.21M shrs HK$43.7M | ||
| 263 |  Celcuity Inc. CELC🇺🇸USD | $69.30 | -0.23% | +15.83% | $3.39B €3.04B | 819.61K shrs $56.8M | |
| 264 | ¥27.64 | -0.68% | +0.44% | ¥24.54B $3.39B · €3.03B | 6.8M shrs ¥187.91M | ||
| 265 | $2.62 | +0.77% | -7.64% | $3.38B €3.03B | 88.9K shrs $232.92K | ||
| 266 | ₩63700.00 | -2.30% | -1.65% | ₩4.69T $3.38B · €3.02B | — | ||
| 267 | ¥12.37 | -1.75% | -2.37% | ¥24.46B $3.38B · €3.02B | 13.21M shrs ¥163.44M | ||
| 268 | $8.91 | +28.76% | -0.63% | $3.33B €2.98B | 32.98M shrs $293.82M | ||
| 269 | $45.08 | +0.67% | +0.33% | $3.3B €2.96B | 909.46K shrs $41M | ||
| 270 | ¥15.90 | -1.85% | +0.95% | ¥23.84B $3.29B · €2.95B | 23.42M shrs ¥372.44M | ||
| 271 | $9.51 | +2.70% | +15.96% | $3.23B €2.89B | 210.32K shrs $2M | ||
| 272 | ¥1286.00 | -0.31% | +1.17% | ¥478.62B $3.21B · €2.87B | 2.04M shrs ¥2.62B | ||
| 273 | $17.04 | +0.35% | +7.55% | $3.18B €2.85B | 1.43M shrs $24.32M | ||
| 274 | $32.89 | -3.15% | +3.61% | $3.17B €2.84B | 1.62M shrs $53.41M | ||
| 275 | ¥5974.00 | -0.81% | +6.10% | ¥473.48B $3.17B · €2.84B | 583.9K shrs ¥3.49B | ||
| 276 | SR 91.20 | +0.22% | -1.63% | SR 11.86B $3.17B · €2.83B | 246.12K shrs SR 22.45M | ||
| 277 |  BB Biotech AG BION.SW🇨🇭CHF | Fr 51.20 | +1.99% | +6.05% | Fr 2.82B $3.16B · €2.83B | 92.51K shrs Fr 4.74M | |
| 278 | NT$65.40 | -3.11% | -8.61% | NT$101.78B $3.16B · €2.82B | 9.39M shrs NT$614.32M | ||
| 279 | €344.50 | -0.86% | -1.64% | €2.89B $3.15B | 3.59K shrs €1.24M | ||
| 280 | $8.46 | -0.47% | +14.53% | $3.13B €2.80B | 1.38M shrs $11.72M | ||
| 281 | ¥19.50 | -3.47% | +2.32% | ¥22.59B $3.12B · €2.79B | 12.79M shrs ¥249.46M | ||
| 282 | ₹1560.65 | -0.28% | -0.74% | ₹258.35B $3.10B · €2.78B | 6.61K shrs ₹10.32M | ||
| 283 | ₹1559.30 | -0.30% | -0.61% | ₹258.13B $3.10B · €2.77B | 117.8K shrs ₹183.68M | ||
| 284 | $19.32 | +0.16% | +4.88% | $3.09B €2.76B | 1.44M shrs $27.87M | ||
| 285 | HK$9.91 | +0.61% | +0.69% | HK$24.11B $3.09B · €2.76B | 6.2M shrs HK$61.41M | ||
| 286 | ¥84.20 | -6.43% | +44.91% | ¥22.29B $3.08B · €2.75B | 6.28M shrs ¥529.18M | ||
| 287 | ¥11.99 | -2.04% | -2.70% | ¥21.89B $3.02B · €2.70B | 12.83M shrs ¥153.84M | ||
| 288 | ¥18.42 | -0.16% | +1.00% | ¥21.74B $3.00B · €2.69B | 7.73M shrs ¥142.32M | ||
| 289 | $28.84 | +0.21% | +0.84% | $2.98B €2.67B | 1.99M shrs $57.4M | ||
| 290 | ₹19280.00 | -3.46% | +3.78% | ₹247.36B $2.97B · €2.66B | 71.65K shrs ₹1.38B | ||
| 291 | ₹19275.95 | -3.70% | +9.19% | ₹247.31B $2.97B · €2.66B | 3.48K shrs ₹67.18M | ||
| 292 | ¥21.20 | -0.61% | +2.68% | ¥21.47B $2.96B · €2.65B | 7.33M shrs ¥155.4M | ||
| 293 | $27.12 | -0.51% | +26.78% | $2.96B €2.65B | 2.26M shrs $61.26M | ||
| 294 | HK$40.20 | -0.84% | +23.30% | HK$23.09B $2.96B · €2.65B | 543.9K shrs HK$21.86M | ||
| 295 | S$1.63 | +0.00% | +1.81% | S$3.97B $2.93B · €2.63B | 1K shrs S$1.63K | ||
| 296 | A$13.21 | -1.97% | +9.22% | A$4.49B $2.92B · €2.61B | 371.06K shrs A$4.9M | ||
| 297 | £233.40 | -0.68% | +14.12% | £2.28B $2.90B · €2.60B | 969.69K shrs £226.33M | ||
| 298 | $24.80 | +2.18% | +6.94% | $2.81B €2.52B | 1.91M shrs $47.24M | ||
| 299 | HK$17.68 | -2.80% | +3.80% | HK$21.95B $2.81B · €2.52B | 4.07M shrs HK$71.99M | ||
| 300 | ¥13.61 | -0.51% | -1.95% | ¥20.33B $2.81B · €2.51B | 9.92M shrs ¥135.06M |
Browse by Country
Europe
Asia